Search Results

There are 124075 results for: content related to: Community melanoma research: From start up to follow up

  1. Clinical trials in gynecological cancer

    International Journal of Gynecological Cancer

    Volume 17, Issue 3, May/June 2007, Pages: 547–556, E.L. TRIMBLE, J. DAVIS, P. DISAIA, K. FUJIWARA, D. GAFFNEY, G. KRISTENSEN, J. LEDERMANN, J. PFISTERER, M. QUINN, N. REED, M. SCHOENFELDT, J.T. THIGPEN and GYNECOLOGIC CANCER INTERGROUP

    Article first published online : 25 JAN 2007, DOI: 10.1111/j.1525-1438.2007.00667.x

  2. You have free access to this content
    Appendix E

    A Clinical Trials Manual from the Duke Clinical Research Institute: Lessons From A Horse Named Jim, Second Edition

    Margaret B. Liu, Kate Davis, Pages: 370–378, 2010

    Published Online : 15 MAR 2010, DOI: 10.1002/9781444315219.app5

  3. You have full text access to this OnlineOpen article
    Characterizing fatigue associated with sunitinib and its impact on health-related quality of life in patients with metastatic renal cell carcinoma

    Cancer

    Volume 120, Issue 12, 15 June 2014, Pages: 1871–1880, David Cella, Mellar P. Davis, Sylvie Négrier, Robert A. Figlin, M. Dror Michaelson, Andrew G. Bushmakin, Joseph C. Cappelleri, Rickard Sandin, Beata Korytowsky, Claudie Charbonneau, Ewa Matczak and Robert J. Motzer

    Article first published online : 13 MAR 2014, DOI: 10.1002/cncr.28660

  4. The effect of docetaxel on developing oedema in patients with breast cancer: a systematic review

    European Journal of Cancer Care

    W. Hugenholtz-Wamsteker, C. Robbeson, J. Nijs, W. Hoelen and M. Meeus

    Article first published online : 27 OCT 2014, DOI: 10.1111/ecc.12261

  5. You have free access to this content
    A randomized, open-label, phase I/II trial to investigate the maximum tolerated dose of the Polo-like kinase inhibitor BI 2536 in elderly patients with refractory/relapsed acute myeloid leukaemia

    British Journal of Haematology

    Volume 163, Issue 2, October 2013, Pages: 214–222, Carsten Müller-Tidow, Gesine Bug, Michael Lübbert, Alwin Krämer, Jürgen Krauter, Peter Valent, David Nachbaur, Wolfgang E. Berdel, Oliver G. Ottmann, Holger Fritsch, Gerd Munzert, Pilar Garin-Chesa, Frank Fleischer, Tillmann Taube and Hartmut Döhner

    Article first published online : 16 AUG 2013, DOI: 10.1111/bjh.12518

  6. Hearing evaluation of patients with head and neck cancer: Comparison of Common Terminology Criteria for Adverse Events, Brock and Chang adverse event criteria in patients receiving cisplatin

    Head & Neck

    A. Dimitrios Colevas, Ruth R. Lira, Electra A. Colevas, Philip W. Lavori, Cato Chan, David B. Shultz and Kay W. Chang

    Article first published online : 11 JUL 2014, DOI: 10.1002/hed.23714

  7. National Cancer Institute–United States strategy regarding intraperitoneal chemotherapy for ovarian cancer

    International Journal of Gynecological Cancer

    Volume 18, Issue s1, March/April 2008, Pages: 26–28, E.L. TRIMBLE and M.C. CHRISTIAN

    Article first published online : 2 SEP 2008, DOI: 10.1111/j.1525-1438.2007.01100.x

  8. Toxicity (Adverse Events)

    Standard Article

    Encyclopedia of Quantitative Risk Analysis and Assessment

    Benjamin Levinson and Judith D. Goldberg

    Published Online : 15 SEP 2008, DOI: 10.1002/9780470061596.risk0633

  9. R-CHOP with iodine-131 tositumomab consolidation for advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0433

    British Journal of Haematology

    Volume 166, Issue 3, August 2014, Pages: 382–389, Jonathan W. Friedberg, Joseph M. Unger, W. Richard Burack, Ajay K. Gopal, Robert N. Raju, Auayporn P. Nademanee, Mark S. Kaminski, Hongli Li, Oliver W. Press, Thomas P. Miller and Richard I. Fisher

    Article first published online : 18 APR 2014, DOI: 10.1111/bjh.12906

  10. You have free access to this content
    A prospective, international phase 2 study of bortezomib retreatment in patients with relapsed multiple myeloma

    British Journal of Haematology

    Volume 160, Issue 5, March 2013, Pages: 649–659, Maria T. Petrucci, Pilar Giraldo, Paolo Corradini, Adriana Teixeira, Meletios A. Dimopoulos, Igor W. Blau, Johannes Drach, Ralf Angermund, Nathalie Allietta, Esther Broer, Vivien Mitchell and Joan Bladé

    Article first published online : 7 JAN 2013, DOI: 10.1111/bjh.12198

  11. Designing and Conducting Phase III Studies

    Standard Article

    Pharmaceutical Sciences Encyclopedia

    Nabil Saba, John Kauh and Dong M. Shin

    Published Online : 15 MAR 2010, DOI: 10.1002/9780470571224.pse212

  12. Clinical features of oral chemotherapy: results of a longitudinal prospective study of breast and colorectal cancer patients receiving capecitabine in the UK

    European Journal of Cancer Care

    Volume 19, Issue 4, July 2010, Pages: 425–433, S.G. BREARLEY, O. CRAVEN, M. SAUNDERS, R. SWINDELL and A. MOLASSIOTIS

    Article first published online : 25 AUG 2009, DOI: 10.1111/j.1365-2354.2009.01114.x

  13. You have free access to this content
    Annual report to the nation on the status of cancer, 1975–2004, featuring cancer in American Indians and Alaska Natives

    Cancer

    Volume 110, Issue 10, 15 November 2007, Pages: 2119–2152, David K. Espey, Xiao-Cheng Wu, Judith Swan, Charles Wiggins, Melissa A. Jim, Elizabeth Ward, Phyllis A. Wingo, Holly L. Howe, Lynn A. G. Ries, Barry A. Miller, Ahmedin Jemal, Faruque Ahmed, Nathaniel Cobb, Judith S. Kaur and Brenda K. Edwards

    Article first published online : 15 OCT 2007, DOI: 10.1002/cncr.23044

  14. You have free access to this content
    Alternate day pomalidomide retains anti-myeloma effect with reduced adverse events and evidence of in vivo immunomodulation

    British Journal of Haematology

    Volume 141, Issue 1, April 2008, Pages: 41–51, Matthew J. Streetly, Kylie Gyertson, Yvonne Daniel, Jerome B. Zeldis, Majid Kazmi and Stephen A. Schey

    Article first published online : 6 MAR 2008, DOI: 10.1111/j.1365-2141.2008.07013.x

  15. You have free access to this content
    The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer

    BJU International

    Volume 102, Issue 11, December 2008, Pages: 1531–1538, Laurence Klotz, Laurent Boccon-Gibod, Neal D. Shore, Cal Andreou, Bo-Eric Persson, Per Cantor, Jens-Kristian Jensen, Tine Kold Olesen and Fritz H. Schröder

    Article first published online : 21 NOV 2008, DOI: 10.1111/j.1464-410X.2008.08183.x

  16. Feasibility study on the MammoSite in early-stage breast cancer: Initial experience

    Australasian Radiology

    Volume 51, Issue 1, February 2007, Pages: 53–61, M Borg, 1 E Yeoh, 1 M Bochner, 2 J Butters, 1 T Van Doorn, 1 G Farshid, 3 J Kollias, 2 D Kotasek, 4 G Gill, 2 A Lim, 1 I Olver, 5 F Parnis and 3 G Rush 6

    Article first published online : 9 JAN 2007, DOI: 10.1111/j.1440-1673.2006.01659.x

  17. You have free access to this content
    Integration of cancer genomics with treatment selection

    Cancer

    Volume 119, Issue 22, 15 November 2013, Pages: 3914–3928, Thomas J. Ow, Vlad C. Sandulache, Heath D. Skinner and Jeffrey N. Myers

    Article first published online : 20 AUG 2013, DOI: 10.1002/cncr.28304

  18. Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma

    British Journal of Haematology

    Valentina Bozzoli, Maria C. Tisi, Elena Maiolo, Eleonora Alma, Silvia Bellesi, Francesco D'Alo’, Maria T. Voso, Giuseppe Leone and Stefan Hohaus

    Article first published online : 29 MAR 2015, DOI: 10.1111/bjh.13358

  19. Safety and Immunogenicity of Recombinant Human Thrombin: A Pooled Analysis of Results from 10 Clinical Trials

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 11, November 2012, Pages: 998–1005, Neil K. Singla, Kevin N. Foster, W. Allan Alexander and John P. Pribble

    Article first published online : 26 OCT 2012, DOI: 10.1002/phar.1128

  20. You have free access to this content
    Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia

    British Journal of Haematology

    Volume 148, Issue 1, January 2010, Pages: 48–58, Thomas R. Chauncey, Holly Gundacker, Mazyar Shadman, Alan F. List, Shaker R. Dakhil, Harry P. Erba, Marilyn L. Slovak, I-Ming Chen, Cheryl L. Willman, Kenneth J. Kopecky and Frederick R. Appelbaum

    Article first published online : 11 OCT 2009, DOI: 10.1111/j.1365-2141.2009.07919.x